Tetsu Kobayashi

5.8k citations

191 papers · 4.5k indexed · h-index 38

Pulmonary and Respiratory Medicine top 1%
Molecular Biology top 5%
Physiology top 5%
Immunology top 5%
Oncology top 5%

Co-authors: Stephen I. Rennard Xiangde Liu Esteban C. Gabazza Osamu Taguchi Fuqiang Wen Qiuhong Fang Tadashi Kohyama Shinji Abe
Topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (20 papers)Asthma and respiratory diseases (18 papers)Neonatal Respiratory Health Research (16 papers)
Cited by: Pulmonary and Respiratory Medicine Internal Medicine Immunology
Journals: Proceedings of the National Academy of SciencesSHILAP Revista de lepidopterologíaThe Journal of Immunology
Partner nations: Japan United States South Korea

In The Last Decade

Tetsu Kobayashi

182 papers receiving 4.4k citations

Peers

Countries citing papers authored by Tetsu Kobayashi

Since Specialization

Citations

This map shows the geographic impact of Tetsu Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsu Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsu Kobayashi more than expected).

Fields of papers citing papers by Tetsu Kobayashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsu Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsu Kobayashi. The network helps show where Tetsu Kobayashi may publish in the future.

Co-authorship network of co-authors of Tetsu Kobayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsu Kobayashi. A scholar is included among the top collaborators of Tetsu Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsu Kobayashi. Tetsu Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Close-to-lesion transbronchial biopsy: a novel technique to improve suitability of specimens for genetic testing in patients with peripheral pulmonary lesions 2023 ·Scientific Reports ·Yoichi Nishii,Tadashi Sakaguchi,(unknown),(unknown),Yuki Nakamura,Yūta Suzuki,Kentaro Ito,Kentaro Fujiwara,Hiroki Yasui,Atsushi Ito,(unknown),(unknown),Corina N. D’Alessandro‐Gabazza,Taro Yasuma,Hajime Fujimoto,Fumihiro Asano,Esteban C. Gabazza,Tetsu Kobayashi,Osamu Taguchi,Osamu Hataji	3
2	Next‐generation sequencing clarified why first‐line treatment with osimertinib was ineffective in an autopsied case of EGFR‐mutated lung squamous cell carcinoma 2023 ·Thoracic Cancer ·T. Nishimura,(unknown),Hajime Fujimoto,(unknown),(unknown),(unknown),(unknown),Masahiro Naito,Yoshinaga Okugawa,Taro Yasuma,(unknown),(unknown),Tetsu Kobayashi,Hidenori Ibata	2
3	Degradation Products of Complex Arabinoxylans by Bacteroides intestinalis Enhance the Host Immune Response 2021 ·Microorganisms ·Taro Yasuma,Masaaki Toda,Ahmed M. Abdel-Hamid,Corina N. D’Alessandro‐Gabazza,Tetsu Kobayashi,Kota Nishihama,(unknown),Gabriel Vasconcelos Pereira,Roderick I. Mackie,Esteban C. Gabazza,Isaac Cann	32
4	Second‐line therapy with first‐ or second‐generation tyrosine kinase inhibitors in EGFR‐mutated non‐small cell lung cancer patients with T790M‐negative or unidentified mutation 2021 ·Thoracic Cancer ·T. Nishimura,(unknown),Masahiro Naito,(unknown),(unknown),(unknown),Taro Yasuma,Hajime Fujimoto,Corina N. D’Alessandro‐Gabazza,(unknown),Tetsu Kobayashi,Esteban C. Gabazza,Hidenori Ibata	3
5	Comparable immunoreactivity rates of PD‐L1 in archival and recent specimens from non‐small cell lung cancer 2018 ·Thoracic Cancer ·Yuki Nakamura,Tetsu Kobayashi,Yoichi Nishii,Yūta Suzuki,(unknown),Kentaro Ito,Fumiaki Watanabe,Kota Nishihama,Taro Yasuma,Corina N. D’Alessandro‐Gabazza,Koji Katsuta,Hajime Fujimoto,Esteban C. Gabazza,Osamu Taguchi,Osamu Hataji	7
6	Mice overexpressing latent matrix metalloproteinase-2 develop lung emphysema after short-term exposure to cigarette smoke extract 2018 ·Biochemical and Biophysical Research Communications ·(unknown),Tetsu Kobayashi,Corina N. D’Alessandro‐Gabazza,Hajime Fujimoto,(unknown),Y. Takahashi,Taro Yasuma,Kota Nishihama,Masaaki Toda,Yoshiyuki Takei,Osamu Taguchi,Esteban C. Gabazza	9
7	The Medicinal Mushroom, Grifola gargal , Ameliorates Allergic Bronchial Asthma 2017 ·Journal of Medicinal Food ·(unknown),Corina N. D’Alessandro‐Gabazza,Masaaki Toda,(unknown),(unknown),Taro Yasuma,Kota Nishihama,Tetsu Kobayashi,Toshimitsu Sumiya,Hirokazu Kawagishi,Esteban C. Gabazza	2
8	“Pseudoprogression” of Pulmonary Pleomorphic Carcinoma during Nivolumab Therapy 2016 ·Journal of Thoracic Oncology ·Kentaro Ito,(unknown),Koji Katsuta,Tetsu Kobayashi,Esteban C. Gabazza,Yasushi Yatabe,Osamu Taguchi,Nobuyuki Yamamoto	27
9	Thrombin-Activatable Fibrinolysis Inhibitor Protects against Acute Lung Injury by Inhibiting the Complement System 2013 ·American Journal of Respiratory Cell and Molecular Biology ·Masahiro Naito,Osamu Taguchi,Tetsu Kobayashi,Takehiro Takagi,Corina N. D’Alessandro‐Gabazza,Yuki Matsushima,(unknown),Paloma Gil-Bernabe,Takahiro Μatsumoto,(unknown),Masaaki Toda,Atsushi Yasukawa,Osamu Hataji,John Morser,Yoshiyuki Takei,Esteban C. Gabazza	23
10	Inhibition of Allergic Bronchial Asthma by Thrombomodulin Is Mediated by Dendritic Cells 2010 ·American Journal of Respiratory and Critical Care Medicine ·Takehiro Takagi,Osamu Taguchi,Masaaki Toda,(unknown),(unknown),Corina N. D’Alessandro‐Gabazza,Yasushi Miyake,Tetsu Kobayashi,Shinya Aoki,Fumiko Chiba,Yutaka Yano,Edward M. Conway,Seiichi Munesue,Yasuhiko Yamamoto,Hiroshi Yamamoto,Koji Suzuki,Yoshiyuki Takei,John Morser,Esteban C. Gabazza	39
11	Cells Derived from the Circulation Contribute to the Repair of Lung Injury 2004 ·American Journal of Respiratory and Critical Care Medicine ·Shinji Abe,Craig Boyer,Xiangde Liu,Fuqiang Wen,Tetsu Kobayashi,Qiuhong Fang,Xingqi Wang,Mitsuyoshi Hashimoto,John Sharp,Stephen I. Rennard	133
12	Synergetic Effect of Interleukin-4 and Transforming Growth Factor-β1 on Type I Collagen Gel Contraction and Degradation by HFL-1 Cells 2003 ·CHEST Journal ·Xiangde Liu,(unknown),Tetsu Kobayashi,Shinji Abe,Qiuhong Fang,Fuqiang Wen,Stephen I. Rennard	7
13	Interferon-γ Reduces Interleukin-4– and Interleukin-13–Augmented Transforming Growth Factor-β2 Production in Human Bronchial Epithelial Cells by Targeting Smads 2003 ·CHEST Journal ·Fuqiang Wen,(unknown),(unknown),Qiuhong Fang,Tetsu Kobayashi,Shinji Abe,Stephen I. Rennard	16
14	Intratracheal Administration of Activated Protein C Inhibits Bleomycin-induced Lung Fibrosis in the Mouse 2001 ·American Journal of Respiratory and Critical Care Medicine ·Hiroki Yasui,Esteban C. Gabazza,Shigenori Tamaki,Tetsu Kobayashi,Osamu Hataji,Hisamichi Yuda,Shino Shimizu,Koji Suzuki,Yukihiko Adachi,Osamu Taguchi	116
15	Long-term Inhalation of High-dose Nitric Oxide Increases Intraalveolar Activation of Coagulation System in Mice 2001 ·American Journal of Respiratory and Critical Care Medicine ·Tetsu Kobayashi,Esteban C. Gabazza,Shino Shimizu,Hiroki Yasui,Hisamichi Yuda,Osamu Hataji,Kazuo Maruyama,Toru Yamauchi,Koji Suzuki,Yukihiko Adachi,Osamu Taguchi	10
16	Type I collagen metabolites as tumor markers in patients with lung carcinoma 1999 ·Cancer ·Tetsu Kobayashi,Esteban C. Gabazza,Osamu Taguchi,Juha Risteli,Leila Risteli,Hiroyasu Kobayashi,Hiroki Yasui,Hisamichi Yuda,Takashi Sakai,(unknown),Yukihiko Adachi	32
17	Protein C Anticoagulant System in Patients with Interstitial Lung Disease 1998 ·American Journal of Respiratory and Critical Care Medicine ·Hiroyasu Kobayashi,Esteban C. Gabazza,Osamu Taguchi,Hideo Wada,Hiroyuki Takeya,Junji Nishioka,Hiroki Yasui,Tetsu Kobayashi,Osamu Hataji,Koji Suzuki,Yukihiko Adachi	57
18	Surface Activity of Sputum From Acute Asthmatic Patients 1997 ·American Journal of Respiratory and Critical Care Medicine ·Kazuyoshi Kurashima,M Fujimura,Takanori Matsuda,Tetsu Kobayashi	43
19	Combined Inhalation of Nitric Oxide and Oxygen in Chronic Obstructive Pulmonary Disease 1997 ·American Journal of Respiratory and Critical Care Medicine ·M. Yoshida,Osamu Taguchi,Esteban C. Gabazza,Tetsu Kobayashi,(unknown),Hiroyuki Kobayashi,Kazuo Maruyama,Takatomo Shima	47
20	[A comparison of asthma deaths and near-fatal asthma attacks]. 1996 ·PubMed ·(unknown),Tetsu Kobayashi,Toshinori Nakagawa,(unknown),(unknown),Yasuyuki Sano,(unknown),Kunihiko Akiyama,(unknown),(unknown),Nobuo Ueda	2

About Tetsu Kobayashi

Tetsu Kobayashi is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 191 papers that have together received 4.5k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (20 papers), Asthma and respiratory diseases (18 papers) and Neonatal Respiratory Health Research (16 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.6k citations), Internal Medicine (126 citations) and Immunology (666 citations). Tetsu Kobayashi has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Stephen I. Rennard, Xiangde Liu, Esteban C. Gabazza, Osamu Taguchi, Fuqiang Wen, Qiuhong Fang, Tadashi Kohyama, Shinji Abe, Corina N. D’Alessandro‐Gabazza and Xingqi Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact